Page last updated: 2024-10-25

cyproheptadine and Benign Neoplasms, Brain

cyproheptadine has been researched along with Benign Neoplasms, Brain in 1 studies

Cyproheptadine: A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc.
cyproheptadine : The product resulting from the formal oxidative coupling of position 5 of 5H-dibenzo[a,d]cycloheptene with position 4 of 1-methylpiperidine resulting in the formation of a double bond between the two fragments. It is a sedating antihistamine with antimuscarinic and calcium-channel blocking actions. It is used (particularly as the hydrochloride sesquihydrate) for the relief of allergic conditions including rhinitis, conjunctivitis due to inhalant allergens and foods, urticaria and angioedema, and in pruritic skin disorders. Unlike other antihistamines, it is also a seratonin receptor antagonist, making it useful in conditions such as vascular headache and anorexia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kacar, S1
Hacioglu, C1
Kar, F1
Sahinturk, V1
Kanbak, G1

Other Studies

1 other study available for cyproheptadine and Benign Neoplasms, Brain

ArticleYear
Cyproheptadine causes apoptosis and decreases inflammation by disrupting thiol/disulfide balance and enhancing the levels of SIRT1 in C6 glioblastoma cells.
    Toxicology in vitro : an international journal published in association with BIBRA, 2021, Volume: 73

    Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Caspase 3; Cel

2021